Antineoplastic Agents, Hormonal Concept

subject area of

• 21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer  Journal Articles
• neu/erbB-2 Overexpression and Response to Hormonal Therapy in Premenopausal Women in the Adjuvant Breast Cancer Setting: Will It Play in Peoria? Part II  Journal Articles
• A Multicenter Phase II Clinical Trial of Lapatinib (GW572016) in Hormonally Untreated Advanced Prostate Cancer  Journal Articles
• A Phase II Study of Leuprolide in Advanced/Recurrent Endometrial Cancer  Journal Articles
• A Randomized Trial Comparing Concurrent versus Sequential Radiation and Endocrine Therapy in Early-Stage, Hormone-Responsive Breast Cancer  Journal Articles
• A Trial of Two Questions  Journal Articles
• A comparison of four treatment strategies for ductal carcinoma in situ using decision analysis  Journal Articles
• A phase II study of sorafenib in patients with chemo-naive castration-resistant prostate cancer  Journal Articles
• A role of SIPL1/SHARPIN in promoting resistance to hormone therapy in breast cancer  Journal Articles
• Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy  Journal Articles
• Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer  Journal Articles
• Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trial  Journal Articles
• American Society of Clinical Oncology Technology Assessment on the Use of Aromatase Inhibitors as Adjuvant Therapy for Women With Hormone Receptor–Positive Breast Cancer: Status Report 2002  Journal Articles
• Aromatase inhibitors in adjuvant therapy for hormone receptor positive breast cancer: A systematic review  Journal Articles
• Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials  Journal Articles
• Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials  Journal Articles
• Assessment of Quality of Life in MA.17: A Randomized, Placebo-Controlled Trial of Letrozole After 5 Years of Tamoxifen in Postmenopausal Women  Journal Articles
• Association of dose escalation of octreotide long‐acting release on clinical symptoms and tumor markers and response among patients with neuroendocrine tumors  Journal Articles
• Attenuation of the Glucocorticoid Response during Ad5IL-12 Adenovirus Vector Treatment Enhances Natural Killer Cell–Mediated Killing of MHC Class I–Negative LNCaP Prostate Tumors  Journal Articles
• Benefit From Exemestane As Extended Adjuvant Therapy After 5 Years of Adjuvant Tamoxifen: Intention-to-Treat Analysis of the National Surgical Adjuvant Breast and Bowel Project B-33 Trial  Journal Articles
• Bone Health and Bone-Targeted Therapies for Nonmetastatic Prostate Cancer  Journal Articles
• Breast Cancer Consensus Meetings: Vive la Difference?  Journal Articles
• Breast cancer in a BRCA2 mutation carrier with a history of prostate cancer  Journal Articles
• Cancer Treatment–Induced Bone Loss in Breast and Prostate Cancer  Journal Articles
• Chemoprevention: Drug pricing and mortality  Journal Articles
• Chemotherapy for older women with node-positive breast cancer.  Journal Articles
• Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer  Journal Articles
• Clinical outcomes of ethnic minority women in MA.17: a trial of letrozole after 5 years of tamoxifen in postmenopausal women with early stage breast cancer  Journal Articles
• Clinical practice guidelines for the care and treatment of breast cancer: adjuvant systemic therapy for node-negative breast cancer (summary of the 2001 update).  Journal Articles
• Coagulopathy in a patient with nephrotic syndrome  Journal Articles
• Comparative Effectiveness of All Available Treatments for Metastatic Hormone-Sensitive Prostate Cancer: A Network Meta-analysis  Journal Articles
• Continuing Outcomes Relevant to Evista: Breast Cancer Incidence in Postmenopausal Osteoporotic Women in a Randomized Trial of Raloxifene  Journal Articles
• Controversies in prostate cancer radiotherapy: consensus development.  Journal Articles
• Current status and future innovations of hormonal agents, chemotherapy and investigational agents in endometrial cancer  Journal Articles
• Duration of Androgen Suppression Before Radiotherapy for Localized Prostate Cancer: Radiation Therapy Oncology Group Randomized Clinical Trial 9910  Journal Articles
• Duration of tamoxifen use and the risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers  Journal Articles
• Effect of Letrozole Versus Placebo on Bone Mineral Density in Women With Primary Breast Cancer Completing 5 or More Years of Adjuvant Tamoxifen: A Companion Study to NCIC CTG MA.17  Journal Articles
• Effect of Single-agent Daily Prednisone on Outcomes and Toxicities in Metastatic Castration-resistant Prostate Cancer: Pooled Analysis of Prospective Studies  Journal Articles
• Effects of Radiotherapy in Early-Stage, Low-Recurrence Risk, Hormone-Sensitive Breast Cancer  Journal Articles
• Effects of a treatment gap during adjuvant chemotherapy in node-positive breast cancer: results of International Breast Cancer Study Group (IBCSG) Trials 13-93 and 14-93  Journal Articles
• Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials  Journal Articles
• Efficacy, Toxicity, and Quality of Life in Older Women With Early-Stage Breast Cancer Treated With Letrozole or Placebo After 5 Years of Tamoxifen: NCIC CTG Intergroup Trial MA.17  Journal Articles
• Endometrial Evaluation with Transvaginal US and Hysterosonography in Asymptomatic Postmenopausal Women with Breast Cancer Receiving Tamoxifen  Journal Articles
• Endometrial cancer. Prevention, detection, management, and follow up.  Journal Articles
• Evaluating the Feasibility of Performing Window of Opportunity Trials in Breast Cancer  Journal Articles
• Extended Adjuvant Endocrine Therapy in Breast Cancer: Current Status and Future Directions  Journal Articles
• Factors Promoting Tamoxifen Resistance in Breast Cancer via Stimulating Breast Cancer Stem Cell Expansion  Journal Articles
• GnRH antagonist associates with less adiposity and reduced characteristics of metabolic syndrome and atherosclerosis compared with orchiectomy and GnRH agonist in a preclinical mouse model1Contributed equally and share first authorship.  Journal Articles
• Growth in Children With Acute Lymphoblastic Leukemia During Treatment  Journal Articles
• Guideline No. 389-Medical Management of Symptomatic Uterine Leiomyomas – An Addendum  Journal Articles
• Health-Related Quality of Life in Men With Metastatic Prostate Cancer Treated With Prednisone Alone or Mitoxantrone and Prednisone  Journal Articles
• High non-compliance in the use of letrozole after 2.5years of extended adjuvant endocrine therapy. Results from the IDEAL randomized trial  Journal Articles
• Imaging, procedural and clinical variables associated with tumor yield on bone biopsy in metastatic castration-resistant prostate cancer  Journal Articles
• Impact of hormonal treatment duration in combination with radiotherapy for locally advanced prostate cancer: Meta-analysis of randomized trials  Journal Articles
• Impact of single-agent daily prednisone on outcomes in men with metastatic castration-resistant prostate cancer  Journal Articles
• International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers  Journal Articles
• Managing Patients on Endocrine Therapy: Focus on Quality-of-Life Issues  Journal Articles
• Managing patients on endocrine therapy: Focus on quality-of-life issues  Conferences
• Markers of Bone Metabolism and Survival in Men with Hormone-Refractory Metastatic Prostate Cancer  Journal Articles
• New-onset psychosis following androgen deprivation therapy for prostate cancer.  Journal Articles
• Novel strategies for systemic treatment of endometrial cancer  Journal Articles
• Oligodendroglioma  Journal Articles
• Omitting Radiotherapy after Breast-Conserving Surgery in Luminal A Breast Cancer  Journal Articles
• Ovarian suppression in combination endocrine adjuvant therapy in premenopausal women with early breast cancer  Journal Articles
• Overview of the Randomized Trials of Radiotherapy in Ductal Carcinoma In Situ of the Breast  Journal Articles
• PREDICTORS OF PATHOLOGICAL STAGE BEFORE NEOADJUVANT ANDROGEN WITHDRAWAL THERAPY AND RADICAL PROSTATECTOMY  Journal Articles
• PSA declines and survival in patients with metastatic castration-resistant prostate cancer treated with enzalutamide  Journal Articles
• Patient-Reported Cognitive Impairment Among Women With Early Breast Cancer Randomly Assigned to Endocrine Therapy Alone Versus Chemoendocrine Therapy: Results From TAILORx  Journal Articles
• Polycomb complex protein BMI1 confers resistance to tamoxifen in estrogen receptor positive breast cancer  Journal Articles
• Postinduction Dexamethasone and Individualized Dosing of Escherichia Coli L-Asparaginase Each Improve Outcome of Children and Adolescents With Newly Diagnosed Acute Lymphoblastic Leukemia: Results From a Randomized Study—Dana-Farber Cancer Institute ALL Consortium Protocol 00-01  Journal Articles
• Predictors of Skeletal Complications in Men with Hormone-Refractory Metastatic Prostate Cancer  Journal Articles
• Primary tumor and patient characteristics in breast cancer as predictors of adjuvant therapy regimen: a regression model  Journal Articles
• Prospective Evaluation of the 21-Gene Recurrence Score Assay for Breast Cancer Decision-Making in Ontario  Journal Articles
• Prospective Validation of a 21-Gene Expression Assay in Breast Cancer  Journal Articles
• Prospects of the Clinical Utilization of Melatonin  Journal Articles
• Prostate cancer: risk categories and role of hormones and radiotherapy.  Journal Articles
• Protective effect of pharmacological castration on metabolic perturbations and cardiovascular disease in the hyperglycemic male ApoE−/−:Ins2+/Akita mouse model  Journal Articles
• Radiation Therapy and Tamoxifen: Concurrent or Sequential? That Is the Question  Journal Articles
• Randomised clinical trial: the safety and efficacy of long‐acting octreotide in patients with portal hypertension  Journal Articles
• Randomized Trial of Tamoxifen Versus Combined Tamoxifen and Octreotide LAR Therapy in the Adjuvant Treatment of Early-Stage Breast Cancer in Postmenopausal Women: NCIC CTG MA.14  Journal Articles
• Re: The Incidence and Relative Risk of Cardiovascular Toxicity in Patients Treated with New Hormonal Agents for Castration-resistant Prostate Cancer  Journal Articles
• Reduction in Tamoxifen Metabolites Endoxifen and N-desmethyltamoxifen With Chronic Administration of Low Dose Cannabidiol: A CYP3A4 and CYP2D6 Drug Interaction  Journal Articles
• Rehabilitation in primary and metastatic brain tumours  Journal Articles
• Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials  Journal Articles
• Remission of Macroglobulinemia during Anastrozole Treatment for Breast Cancer  Journal Articles
• Resolution of Catamenial Epilepsy after Goserelin Therapy and Oophorectomy: Case Report of Presumed Cerebral Endometriosis  Journal Articles
• Role of aromatic substituents on the antiproliferative effects of diphenyl ferrocenyl butene compounds  Journal Articles
• Sensitization of human melanoma cells by tamoxifen to apoptosis induction by pancratistatin, a nongenotoxic natural compound  Journal Articles
• Synergy of pancratistatin and tamoxifen on breast cancer cells in inducing apoptosis by targeting mitochondria  Journal Articles
• Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015  Journal Articles
• Tamoxifen Derivatives for Delivery of the Antitumoral (DACH)Pt Group: Selective Synthesis by McMurry Coupling, and Biochemical Behaviour  Journal Articles
• Tamoxifen May Be an Effective Adjuvant Treatment for BRCA1-Related Breast Cancer Irrespective of Estrogen Receptor Status  Journal Articles
• Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: An update  Journal Articles
• Tamoxifen for Breast Cancer Risk Reduction  Journal Articles
• Tamoxifen for early breast cancer: an overview of the randomised trials  Journal Articles
• The First Organometallic Selective Estrogen Receptor Modulators (SERMs) and Their Relevance to Breast Cancer  Journal Articles
• The association between tamoxifen and the development of hepatocellular carcinoma: case report and literature review.  Journal Articles
• The effects of lymph node status on predicting outcome in ER+ /HER2- tamoxifen treated breast cancer patients using gene signatures  Journal Articles
• The evidence for tamoxifen and chemotherapy as treatment for metastatic melanoma  Journal Articles
• The experiences of men receiving androgen deprivation treatment for prostate cancer: a qualitative study.  Journal Articles
• The use and toxicity of steroids in the management of patients with brain metastases  Journal Articles
• Therapeutic options in advanced prostate cancer: Present and future  Journal Articles
• Towards optimal endocrine therapy for hormone-sensitive breast cancer: Initial versus sequential adjuvant aromatase inhibition  Journal Articles
• Treatment of Hormone-Refractory Prostate Cancer with Docetaxel or Mitoxantrone: Relationships between Prostate-Specific Antigen, Pain, and Quality of Life Response and Survival in the TAX-327 Study  Journal Articles
• Words or Wisdom: Re: The Incidence and Relative Risk of Cardiovascular Toxicity in Patients Treated with New Hormonal Agents for Castration-resistant Prostate Cancer.  Journal Articles
• [Medroxyprogesterone Acetate as Part of Palliative Care for Terminal-Stage Breast Cancer Patients--A Report of Two Cases].  Journal Articles